Use of Fluorescein Dye for the Removal of Brain Tumors

Completed

Conditions studied: Brain Neoplasms

In brief

Fluorescein is a dye agent that can be injected through an intravenous line. It has been shown to help tell the difference between brain tumor tissue and normal brain tissue when it is used together with a specialized filter on a microscope in the operating room. The investigators plan to study the use of fluorescein in the removal of brain tumors at a low dose.

Key facts

Study ID

NCT02389530

Run by

University of Pittsburgh

People needed

91

Starts

2015-05-01

Expected to finish

2018-06-01

Last updated by the study team

2018-08-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age of 18 or greater
• Plan for elective removal of a brain tumor at UPMC Shadyside with either Dr. Engh or Dr. Amankulor.

You may not qualify if…

• History of adverse reaction to fluorescein.
• Emergent surgical procedure (consent not feasible).
• Creatinine of > 2.0 (drug is excreted renally).
• Known ongoing pregnancy.

Where it is running

• UPMC Shadyside Hospital — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.